Marsh & McLennan Companies (NYSE:MRSH) Releases Earnings Results, Beats Estimates By $0.08 EPS

Key Points

• Q1 beat: Marsh & McLennan reported adjusted EPS of $3.29, beating estimates by $0.08, with revenue up roughly 8% year‑over‑year to about $7.3–$7.6 billion; the company repurchased $750 million of stock and guided to similar underlying revenue growth in 2026 with continued margin expansion.
• $425 million legal charge: The quarter included a $425 million charge related to ongoing litigation from the Greensill Capital collapse, recorded as the firm's best estimate after mediation and remaining unresolved.
• AI and capital plan: Management is investing heavily in AI (products like Ada, Sentrisk, Euclid, GC QuoteBox) with early efficiency gains (~20% on document ingestion) and expects AI‑driven productivity to support margin improvement while targeting about $5 billion of capital deployment in 2026 across dividends, acquisitions and buybacks.

Marsh & McLennan Companies (NYSE:MRSH - Get Free Report) announced its earnings results on Thursday. The financial services provider reported $3.29 EPS for the quarter, beating analysts' consensus estimates of $3.21 by $0.08, FiscalAI reports. The business had revenue of $7.30 billion for the quarter. Marsh & McLennan Companies had a net margin of 14.26% and a return on equity of 31.87%. The firm's revenue for the quarter was up 7.6% on a year-over-year basis.

Here are the key takeaways from Marsh & McLennan Companies' conference call:

• Q1 results — Revenue rose 8% to $7.6 billion (4% underlying), adjusted operating income and adjusted EPS each grew 8% (adjusted EPS $3.29), and the company repurchased $750 million of stock while guiding to similar underlying revenue growth in 2026 with continued margin expansion.
• AI strategy — Marsh is investing heavily in AI across three pillars (growth, productivity, efficiency) with products like Ada, Sentrisk, Euclid and GC QuoteBox and early wins (e.g., document ingestion improving efficiency ~20%), which management says will fund growth investments and support margin improvement.
• Legal charge — The quarter included a $425 million charge related to ongoing litigation stemming from the Greensill Capital collapse, recorded as the company's best estimate of liability after mediation; the matter remains unresolved.
• Market and interest-rate headwinds — Pricing pressure persists (Marsh index: primary commercial rates down 5%, global property down 9%; reinsurance non-loss accounts down 15–20%) and fiduciary interest income declined $18 million to $85 million in Q1, with Q2 fiduciary income expected around $80 million.
• Capital deployment — Management expects to deploy about $5 billion of capital in 2026 across dividends, acquisitions and buybacks (balanced, disciplined approach), and says the M&A pipeline is active while buybacks will flex with acquisition activity.

Marsh & McLennan Companies Price Performance

Shares of MRSH stock opened at $176.35 on Friday. The stock has a market cap of $85.38 billion, a price-to-earnings ratio of 22.04, a P/E/G ratio of 2.51 and a beta of 0.75. Marsh & McLennan Companies has a 1-year low of $164.89 and a 1-year high of $235.78. The company has a debt-to-equity ratio of 1.28, a quick ratio of 1.10 and a current ratio of 1.11. The business's 50-day moving average is $173.66.

Marsh & McLennan Companies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Thursday, April 9th will be issued a dividend of $0.90 per share. This represents a $3.60 annualized dividend and a dividend yield of 2.0%. The ex-dividend date is Thursday, April 9th. Marsh & McLennan Companies's dividend payout ratio is presently 42.70%.

Insider Buying and Selling at Marsh & McLennan Companies

In other news, CEO John Q. Doyle sold 16,655 shares of the stock in a transaction dated Wednesday, March 4th. The shares were sold at an average price of $183.30, for a total transaction of $3,052,861.50. Following the transaction, the chief executive officer directly owned 116,811 shares in the company, valued at $21,411,456.30. This represents a 12.48% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. 0.38% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the business. Pinnacle Bancorp Inc. purchased a new position in Marsh & McLennan Companies in the third quarter valued at approximately $25,000. Solstein Capital LLC purchased a new position in Marsh & McLennan Companies in the fourth quarter valued at approximately $25,000. SHP Wealth Management purchased a new position in Marsh & McLennan Companies in the fourth quarter valued at approximately $26,000. KERR FINANCIAL PLANNING Corp purchased a new position in Marsh & McLennan Companies in the fourth quarter valued at approximately $27,000. Finally, Golden State Wealth Management LLC purchased a new position in Marsh & McLennan Companies in the fourth quarter valued at approximately $27,000. Hedge funds and other institutional investors own 87.99% of the company's stock.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on MRSH shares. Cantor Fitzgerald upped their price target on shares of Marsh & McLennan Companies from $208.00 to $212.00 and gave the stock an "overweight" rating in a research note on Monday, February 2nd. JPMorgan Chase & Co. lowered their price target on shares of Marsh & McLennan Companies from $226.00 to $206.00 and set an "overweight" rating on the stock in a research note on Thursday, April 9th. Royal Bank Of Canada reaffirmed a "sector perform" rating and set a $200.00 price target on shares of Marsh & McLennan Companies in a research note on Friday, January 30th. Citigroup upped their price target on shares of Marsh & McLennan Companies from $201.00 to $205.00 and gave the stock a "neutral" rating in a research note on Tuesday, February 3rd. Finally, Wells Fargo & Company lowered their price target on shares of Marsh & McLennan Companies from $203.00 to $178.00 and set an "equal weight" rating on the stock in a research note on Thursday, April 9th. One equities research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, ten have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of $205.33.

Trending Headlines about Marsh & McLennan Companies

Here are the key news stories impacting Marsh & McLennan Companies this week:

• Positive Sentiment: Q1 results beat expectations — non‑GAAP EPS $3.29 vs. ~$3.21 estimate and revenue roughly $7.3B with ~8% year‑over‑year growth; Mercer/consulting drove strength. Marsh (MRSH) Beats Q1 Earnings and Revenue Estimates
• Positive Sentiment: Earnings call highlighted continued growth initiatives and AI investments that management says support long‑term revenue/consulting momentum — a potential positive catalyst for future margins. Marsh & McLennan Earnings Call Highlights Growth and AI
• Positive Sentiment: Keefe, Bruyette & Woods raised its price target to $203 (market‑perform), implying upside from current levels — a modest vote of confidence from an analyst. Price Target Raise
• Neutral Sentiment: Commentary and analyst pieces note that valuation looks more attractive after the pullback — could attract value buyers but depends on execution and margin trends. Marsh & McLennan: The Valuation May Finally Be Here
• Negative Sentiment: Bank of America maintained a sell rating on MRSH, providing a counterweight to upbeat results and likely contributing to short‑term selling pressure. Bank of America Sticks to Sell Rating
• Negative Sentiment: Company disclosed a new regulation‑category risk that could materially affect financial performance — an added uncertainty that can weigh on sentiment until clarified. Regulatory Risk Disclosure

Marsh & McLennan Companies Company Profile

Marsh & McLennan Companies NYSE: MMC is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.